CASANDRA BLAIR: Open Payments
NPI 1710413612 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 32 payments from 11 companies in 2025. Trend: 2023 $1,120 · 2024 $379 · 2025 $502
Food & beverage: $457Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $199 |
| Novo Nordisk Inc | 5 | $89 |
| Lilly USA, LLC | 2 | $59 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Ardelyx, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $15 |
| Cipher Pharmaceuticals US LLC | 1 | $14 |
Products named: UBRELVY, QULIPTA, Wegovy, Ozempic, Auvelity, IBSRELA, INGREZZA, XIFAXAN.
Industry payments across VA — which companies pay providers there.
